BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Ezetimibe

An azetidine derivative and ANTICHOLESTEREMIC AGENT that inhibits intestinal STEROL absorption. It is used to reduce total CHOLESTEROL; LDL CHOLESTEROL, and APOLIPOPROTEINS B in the treatment of HYPERLIPIDEMIAS.

296+ PubMed studies analyzed · 48 RCTs · Evidence Score: 54.8

Research Domains

Ezetimibe has been studied across 15 research domains including 😴 Sleep, ❤️ Cardiovascular, 🔥 Metabolic, 🦠 Gut & Microbiome, 🫁 Liver & Detox. The primary research focus is 😴 Sleep with 65% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ezetimibe, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Flutamide
21 shared targets
Beclomethasone
16 shared targets
Polidocanol
16 shared targets
Simvastatin
22 shared targets
Fluocinolone
13 shared targets
trequinsin
17 shared targets
Itraconazole
13 shared targets
Methyltestosterone
14 shared targets
Ritonavir
20 shared targets
Nicardipine
15 shared targets
Loading evidence profile...

This evidence profile for Ezetimibe is generated deterministically from 296 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.